Cardio,Cardiovascular News,Cardiologists,Medicines,Heart Health,EKG

* Internet Search Results

*** Search Filter: "NewJersey"

Barry Manilow: The Last Nashville Concert - Bridgestone Arena
The Barry Manilow concert originally scheduled for March 7, 2026 at Bridgestone Arena has been rescheduled to Saturday, August 1. All previously purchased tickets will be honored at the new date.

Barry Manilow - 2026 Tour Dates & Concert Schedule - Live Nation
Find concert tickets for Barry Manilow upcoming 2026 shows. Explore Barry Manilow tour schedules, latest setlist, videos, and more on livenation.com.

Barry Manilow: The Last Nashville Concert at Bridgestone Arena
About This Show Join Barry Manilow for his last Nashville concert. Sing along to iconic hits in this unforgettable farewell performance.

Barry Manilow Setlist at Bridgestone Arena, Nashville
Get the Barry Manilow Setlist of the concert at Bridgestone Arena, Nashville, TN, USA on August 1, 2026 from the The Last Concerts Tour and other Barry Manilow Setlists for free on setlist.fm!

Barry Manilow | The official homepage of Barry Manilow, the showman of ...
Experience an exciting treasure trove of concerts, one time only benefits, award evenings, private shows, rehearsals and many more.

BARRY MANILOW ANNOUNCES SIX NEW ARENA SHOWS IN MARCH 2026
January 13, 2026: Music icon Barry Manilow has announced six new arena shows in March 2026. The GRAMMY®, TONY®, and EMMY® Award winner will bring his high-energy, hit-packed concert to Charlotte, Norfolk, Baltimore, Cincinnati, Nashville and Lexington, marking his final concerts in these cities.

Barry Manilow Cancels Shows Due to Illness amid His Las Vegas Comeback ...
Barry Manilow cut his Oct. 9 Las Vegas show short after two songs and then canceled his Oct. 10 show. ‘After a triumphant welcome-back concert on Thursday, Barry got hit with bronchitis and had ...

’70s Music Icon Announces Update on 2026 Farewell Tour
Barry Manilow has shared the rescheduled dates for his upcoming farewell tour in the U.S. after receiving medical advice to prioritize healing after undergoing lung surgery.

Barry Manilow returns to the stage after six-week hiatus following ...
Barry Manilow returns to the stage after six-week hiatus following health break Barry Manilow performs onstage during the 67th Grammy Awards Pre-Grammy Gala.

Barry Manilow Makes Decision to Take a Break Following Health Struggles
Barry Manilow has been eager to get back onstage and perform for his devoted fans, but ongoing health struggles have prevented him from doing so multiple times this year. Manilow, who is 83, announced an important update on Tuesday, August 25, telling fans he would take a much-needed break to focus on his health and recovery.

* Latest OCD 101 News

*** News Filter: "NewJersey"

Unexpected Improvement in Obsessive-Compulsive Disorder Symptoms Following Initiation of Bupropion  Psychiatrist.com
Parents urge NJ to mandate health insurance coverage for rare pediatric condition  New Jersey Monitor
NeuroBoost Launches Clinic Providing Transcranial Magnetic Stimulation for Depression in New Jersey  USA Today
Nicole M. Torella Obituary (2026) - Fanwood, NJ - Higgins Home for Funerals, Inc.  Legacy | Obituary
NeuroBoost Launches in New Jersey to Expand Access to TMS  USA Today
Singing the national anthem before sporting events has helped this South Jersey woman cope with OCD  PhillyVoice
InStride Health Expands in New Jersey to Meet the Need for Insurance-Based Pediatric Anxiety and OCD Treatment  PR Newswire
NJ legislators advance bill to legalize psychedelic drug found in mushrooms  New Jersey Monitor
Parent files bullying lawsuit against Bergen County school district  Bergen Record
Researchers Discover Dozens of Genes Tied to OCD and Tic Disorders | Newswise  Newswise
Teens with Tourette syndrome learn how to be their own advocates  NJ Spotlight News
Dealing with mental health and the coronavirus: ‘It’s triggering’  Inquirer.com
Sister Mary Magdalen of the Cross Obituary Oct 14, 2024  Holcombe-Fisher Funeral Home
Country star opens up about condition  NJ.com
Westfield Parents Host 26th Annual Awareness Expo (Photos)  Patch

Common Cardiovascular Symptoms & Warning Signs

Chest Pain or Pressure (Angina) — Sensation of squeezing, fullness, or tightness in the center of the chest that may radiate to the jaw, neck, back, or arm.
Shortness of Breath (Dyspnea) — Difficulty breathing or feeling winded during routine activities, exertion, or while lying flat in bed.
Palpitations or Irregular Heartbeat — Sensations of a racing, fluttering, pounding, or skipping heart rate.
Unexplained Dizziness or Lightheadedness — Sudden feelings of faintness, loss of balance, or near-syncope linked to decreased blood flow to the brain.
Swelling in the Extremities (Edema) — Fluid retention causing notable swelling in the legs, ankles, feet, or abdomen.
Unusual Fatigue and Weakness — Persistent tiredness or exhaustion during simple daily tasks, often an early warning sign of heart failure.
Cold Sweats or Diaphoresis — Sudden onset of unexplained profuse sweating accompanied by chest discomfort or anxiety.
Cyanosis or Pale Skin Tone — A bluish or abnormally pale discoloration of the skin, lips, or nail beds due to poor oxygen circulation.
Persistent Coughing or Wheezing — Chronic cough producing white or pink blood-tinged mucus caused by fluid accumulation in the lungs.
Pain in the Extremities (Claudication) — Cramping or aching in the calves, thighs, or hips during walking, indicating peripheral artery disease.

Current Cardiovascular Treatments

Dual GIP/GLP-1 Receptor Agonists — Advanced metabolic agents like tirzepatide cut major adverse cardiovascular events, reduce systemic vascular inflammation, and improve heart failure outcomes.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation therapy replacing traditional radiofrequency ablation to treat atrial fibrillation with greater tissue selectivity and safety.
SGLT2 Inhibitor Therapy — Guideline-directed medical treatment (e.g., dapagliflozin, empagliflozin) initiated early to reduce hospitalizations and mortality across heart failure spectrums.
Targeted siRNA & Lipid Gene Therapy — Small interfering RNA injectables (like inclisiran) and gene-editing therapies (VERVE-102) providing long-term LDL-C reduction with single-dose schedules.
Transcatheter Valve Therapies (TAVR / TMVR) — Minimally invasive catheter interventions for replacing or repairing severe aortic, mitral, and tricuspid valve stenosis/regurgitation without open-heart surgery.
Aldosterone Synthase Inhibitors — Targeted hormonal pathway medications, such as baxdrostat, designed to treat treatment-resistant hypertension by lowering aldosterone production.
Left Bundle Branch Area Pacing (LBBAP) — Conduction system pacing delivering direct physiological resynchronization as a superior alternative to traditional cardiac resynchronization therapy.
Dual Endothelin Receptor Antagonists — Novel oral therapies like aprocitentan used in combination regimes to target resistant high blood pressure through specialized vascular pathways.
Targeted Anti-Inflammatory Agents — Low-dose colchicine and specialized anti-inflammatory protocols aimed directly at preventing plaque rupture and reducing residual cardiovascular risk.
Mechanical Decompression Systems — Endovascular venous balloon technology and advanced left ventricular assist devices designed to acutely unload intracardiac pressures during heart failure crises.

Key Milestones in Cardiovascular History

Discovery of Blood Circulation (1628) — William Harvey published De Motu Cordis, demonstrating for the first time that blood circulates continuously through the body pumped by the heart.
Invention of the Stethoscope (1816) — René Laennec invented the wooden stethoscope, allowing physicians to auscultate and diagnose internal cardiac sounds non-invasively.
First Human Electrocardiogram (1902) — Willem Einthoven developed the string galvanometer to record the electrical activity of the heart, inventing the modern ECG.
First Human Cardiac Catheterization (1929) — Werner Forssmann performed the first successful cardiac catheterization on himself, opening the path for modern interventional cardiology.
Launch of the Framingham Heart Study (1948) — A landmark long-term epidemiological study began, establishing major risk factors like high blood pressure, cholesterol, and smoking.
Development of the Cardiopulmonary Bypass (1953) — John Gibbon successfully used a heart-lung machine on a human patient, enabling modern open-heart surgery.
First Successful Human Heart Transplant (1967) — Dr. Christiaan Barnard performed the world's first human-to-human heart transplant in Cape Town, South Africa.
First Coronary Angioplasty (1977) — Andreas Grüntzig performed the first successful percutaneous transluminal coronary angioplasty (PTCA) to open blocked arteries.
Introduction of Coronary Stents (1986) — Ulrich Sigwart and Jacques Puel implanted the first coronary stent in a human heart to prevent artery restenosis.
First TAVR Procedure (2002) — Alain Cribier performed the first Transcatheter Aortic Valve Replacement, revolutionizing treatment for aortic stenosis without open-heart surgery.

Current Cardiovascular Research & Breakthroughs

Gene-Editing for Lipid Lowering — Advanced base-editing and RNA therapies (such as VERVE-102) show potential for permanently reducing LDL cholesterol with single-dose targeted gene inactivation.
AI-Driven Predictive Diagnostics — Deep learning algorithms now evaluate polygenic risk scores and real-time imaging data to predict cardiac events years before clinical symptoms appear.
Stem Cell Remuscularization — Regenerative cardiac cell therapies using stem-cell-derived cardiomyocytes aim to repair post-infarct scar tissue and restore contractile function.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation technology is transforming arrhythmia management by selectively isolating cardiac tissue with lower procedural risk.
Anti-Inflammatory Therapies — Target-specific anti-inflammatory drugs are being validated to reduce residual vascular risk and suppress ongoing atheroma plaque progression.
Transcatheter Valve Evolution (TMVR/TAVR) — Next-generation transcatheter systems are expanding treatment options for complex structural valve conditions without traditional open surgery.
Digital Twin Hemodynamic Modeling — Virtual patient-specific cardiac models integrate imaging and biomarkers to simulate interventional outcomes before execution.
Conduction System Pacing (LBBAP) — Left bundle branch area pacing is replacing traditional biventricular pacing to provide more natural physiological resynchronization.
Cardioprotective Metabolic Drugs — Broadening applications of SGLT2 inhibitors and GLP-1 receptor agonists demonstrate significant reductions in heart failure admissions and vascular events.
Novel Aldosterone Synthase Inhibitors — New drug classes like Baxdrostat provide target-specific control for resistant hypertension by directly modulating hormone pathways.